SB 140 Colorado Senate · 2026 Regular Session

Exempt Drugs from Prescription Drug Affordability Board Reviews

Summary
The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)
Bill status passed 3 of 5 stages cleared
Introduction
Mar 2026
Committee Review
Apr 2026
Senate Passage
Apr 2026
House Passage
Governor
Introduced Mar 16, 2026 Last action Apr 22, 2026
Maddy AI version diff · 2 comparisons

What changed between versions

Engrossed Reengrossed · 3 edits · Apr 13, 2026
MINOR
The bill was reengrossed to include additional Senate sponsors, and the summary section was updated to clarify that the current text reflects the unamended version as of April 13, 2026, while noting that a new summary for the reengrossed version will be posted later. These changes are primarily administrative and informational, ensuring accurate record-keeping and transparency for the legislative process.
TECHNICAL

Added new sponsors: Baisley, Coleman, Liston, Pelton B., and Pelton R.

Updated the bill title from 'ENGROSSED' to 'REENGROSSED' and adjusted the accompanying text to reflect that amendments were adopted in the House of Introduction.

Inserted a notice stating the bill summary applies to the unamended version as of April 13, 2026, and that a future summary will cover the reengrossed version.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
8
Key actions
3
Committee
2
Apr 22, 2026
Lower · Passed
House Committee on Health & Human Services Postpone Indefinitely
lower
Apr 21, 2026
Introduced
Introduced In House - Assigned to Health & Human Services
lower
Apr 13, 2026
Upper · Passed
Senate Third Reading Passed - No Amendments
upper
Apr 2, 2026
Upper · Passed
Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
upper
Mar 16, 2026
Introduced
Introduced In Senate - Assigned to Health & Human Services
upper
14 primary · 5 co-sponsors

Sponsors